GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

EPA:ALGEV • FR0000033888

168 EUR
-7 (-4%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

4

Overall ALGEV gets a fundamental rating of 4 out of 10. We evaluated ALGEV against 112 industry peers in the Machinery industry. While ALGEV has a great health rating, there are worries on its profitability. ALGEV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ALGEV had positive earnings in the past year.
  • In the past year ALGEV had a positive cash flow from operations.
  • In the past 5 years ALGEV has always been profitable.
  • ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • With a Return On Assets value of 0.13%, ALGEV is not doing good in the industry: 72.32% of the companies in the same industry are doing better.
  • The Return On Equity of ALGEV (0.16%) is worse than 71.43% of its industry peers.
  • ALGEV has a worse Return On Invested Capital (0.48%) than 79.46% of its industry peers.
  • ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.65%.
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROIC 0.48%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.23%, ALGEV is doing worse than 72.32% of the companies in the same industry.
  • ALGEV's Profit Margin has declined in the last couple of years.
  • ALGEV has a Operating Margin of 0.97%. This is amonst the worse of the industry: ALGEV underperforms 80.36% of its industry peers.
  • ALGEV's Operating Margin has declined in the last couple of years.
  • The Gross Margin of ALGEV (59.17%) is better than 82.14% of its industry peers.
  • In the last couple of years the Gross Margin of ALGEV has remained more or less at the same level.
Industry RankSector Rank
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALGEV is destroying value.
  • Compared to 1 year ago, ALGEV has less shares outstanding
  • Compared to 5 years ago, ALGEV has less shares outstanding
  • Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ALGEV has an Altman-Z score of 3.65. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.
  • ALGEV has a Altman-Z score of 3.65. This is in the better half of the industry: ALGEV outperforms 79.46% of its industry peers.
  • ALGEV has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as ALGEV would need 2.95 years to pay back of all of its debts.
  • ALGEV has a Debt to FCF ratio of 2.95. This is in the better half of the industry: ALGEV outperforms 74.11% of its industry peers.
  • ALGEV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • ALGEV has a better Debt to Equity ratio (0.04) than 88.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Altman-Z 3.65
ROIC/WACC0.06
WACC7.98%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ALGEV has a Current Ratio of 5.07. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
  • ALGEV has a Current ratio of 5.07. This is amongst the best in the industry. ALGEV outperforms 97.32% of its industry peers.
  • ALGEV has a Quick Ratio of 3.68. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ALGEV (3.68) is better than 97.32% of its industry peers.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 3.68
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

  • The earnings per share for ALGEV have decreased strongly by -96.89% in the last year.
  • The earnings per share for ALGEV have been decreasing by -17.19% on average. This is quite bad
  • The Revenue has been growing slightly by 2.81% in the past year.
  • Measured over the past years, ALGEV shows a small growth in Revenue. The Revenue has been growing by 5.90% on average per year.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

  • ALGEV is valuated quite expensively with a Price/Earnings ratio of 373.33.
  • ALGEV's Price/Earnings ratio is a bit more expensive when compared to the industry. ALGEV is more expensive than 72.32% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ALGEV to the average of the S&P500 Index (27.97), we can say ALGEV is valued expensively.
  • A Price/Forward Earnings ratio of 12.41 indicates a correct valuation of ALGEV.
  • 66.07% of the companies in the same industry are more expensive than ALGEV, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, ALGEV is valued rather cheaply.
Industry RankSector Rank
PE 373.33
Fwd PE 12.41
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • ALGEV's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, ALGEV is valued a bit more expensive than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 38.75
EV/EBITDA 12.6
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)105.23
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

  • ALGEV has a Yearly Dividend Yield of 2.92%.
  • Compared to an average industry Dividend Yield of 1.45, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 85.71% of the companies listed in the same industry.
  • ALGEV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

  • On average, the dividend of ALGEV grows each year by 21.15%, which is quite nice.
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

  • ALGEV pays out 1132.65% of its income as dividend. This is not a sustainable payout ratio.
  • ALGEV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP1132.65%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (2/13/2026, 7:00:00 PM)

168

-7 (-4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30
Earnings (Next)04-30
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap126.00M
Revenue(TTM)148.53M
Net Income(TTM)340.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP1132.65%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 373.33
Fwd PE 12.41
P/S 0.85
P/FCF 38.75
P/OCF 15.99
P/B 0.6
P/tB 0.6
EV/EBITDA 12.6
EPS(TTM)0.45
EY0.27%
EPS(NY)13.53
Fwd EY8.06%
FCF(TTM)4.34
FCFY2.58%
OCF(TTM)10.51
OCFY6.26%
SpS198.04
BVpS281.9
TBVpS277.87
PEG (NY)105.23
PEG (5Y)N/A
Graham Number53.42
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROCE 0.64%
ROIC 0.48%
ROICexc 0.57%
ROICexgc 0.58%
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
FCFM 2.19%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Debt/EBITDA 0.99
Cap/Depr 66.07%
Cap/Sales 3.12%
Interest Coverage 250
Cash Conversion 93.23%
Profit Quality 956.47%
Current Ratio 5.07
Quick Ratio 3.68
Altman-Z 3.65
F-Score5
WACC7.98%
ROIC/WACC0.06
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.81%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y261.56%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status for ALGEV stock?

ChartMill assigns a valuation rating of 2 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


What is the profitability of ALGEV stock?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


What is the valuation of GEVELOT SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GEVELOT SA (ALGEV.PA) is 373.33 and the Price/Book (PB) ratio is 0.6.


How sustainable is the dividend of GEVELOT SA (ALGEV.PA) stock?

The dividend rating of GEVELOT SA (ALGEV.PA) is 5 / 10 and the dividend payout ratio is 1132.65%.